Drug Industry Documents Archive
The Drug Industry Documents Archive (DIDA) is a digital archive of
clinical trials, publication of study results, pricing, marketing, relations with physicians and drug company involvement in continuing medical education
.
Most of the documents on DIDA were made public as a result of lawsuits against pharmaceutical companies
Abbott Labs, among others. DIDA was founded in 2005 with the support of a gift by Thomas Greene, the attorney for David Franklin, whistleblower in United States ex rel. Franklin v. Parke-Davis, the case from which the first documents in the archive originated.[1]
Researchers as well as students, journalists, and the general public, use the archive to investigate the ways pharmaceutical companies market their products. The UCSF_Library created this digital archive in an attempt to facilitate further research into the drug industry's practice of establishing close links with the medical community which has been shown to influence scientific research, drug approval, prescription practices, and ultimately, consumer health.[2][3]
Collections
DIDA contains:
- internal pharmaceutical company documents
- correspondence between drug companies and physicians, researchers and educational institutions
- regulatory and legal documents
- court filings
- depositions
- expert reports
- internal University documents
Documents come from a variety of sources including:
- Lawsuits against Vioxx
- The landmark whistleblower case involving Neurontin (gabapentin) and off-label marketing: United States of America ex rel. David Franklin vs. Parke-Davis, Division of Warner-Lambert/Pfizer
- Investigations into Charles Grassley(R-Iowa)
- Investigations into the marketing of Vioxx to physicians by the Henry A. Waxman
- Norvir
- Lawsuits against Premarin to women. Wyeth paid medical ghostwritersto author journal articles about the drug.
References
- ^ "About the Project". Drug Industry Document Archive.
- PMID 16908919.
- PMID 18413874.
Further reading
- Hill, K.; et al. (2008). "The ADVANTAGE Seeding Trial: A Review of Internal Documents". Annals of Internal Medicine. 149 (4): 251–258. PMID 18711155.
- Landefeld, S; Steinman, M. (January 2009). "The Neurontin Legacy - Marketing through Misinformation". NEJM. 360 (2): 103–6. PMID 19129523.
- Waxman, HA. Memorandum to the Democratic Members of the Government Reform Committee: The marketing of Vioxx to physicians. May 5, 2005. Committee on Government Reform Minority Office, United States House of Representatives.